Global News Elevar Therapeutics Announces FDA Acceptance of New Drug Application Filing for Rivoceranib in Combination with Camrelizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma 17 7 月, 2023 Admin FORT LEE, NJ, July 17, 2023 (G…